Teva Pharmaceutical Industries Ltd (NYSE:TEVA)

8.76
Delayed Data
As of Oct 28
 +0.02 / +0.23%
Today’s Change
6.25
Today|||52-Week Range
13.76
-10.61%
Year-to-Date

Stock Price Forecast

The 19 analysts offering 12-month price forecasts for Teva Pharmaceutical Industries Ltd have a median target of 11.00, with a high estimate of 17.00 and a low estimate of 8.00. The median estimate represents a +25.57% increase from the last price of 8.76.

Analyst Recommendations

The current consensus among 24 polled investment analysts is to Hold stock in Teva Pharmaceutical Industries Ltd. This rating has held steady since October, when it was unchanged from a Hold rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$0.58
Sales
$4.1B
Reporting Date
Nov 05

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 5.84%
 
 
 
 
 
 
Growthannually 4.40%
 
 
 
 
 
 

Sales

Growthquarterly 5.19%
 
 
 
 
 
 
Growthannually -1.22%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.